Education and Training
- Fellowship, Hematology / Oncology, Duke University School of Medicine, 2010 - 2013
- Residency, General Internal Medicine, Duke University School of Medicine, 2006 - 2009
- M.D., Duke University, 2006
Moffitt, AB, Ondrejka, SL, McKinney, M, Rempel, RE, Goodlad, JR, Teh, CH, Leppa, S, Mannisto, S, Kovanen, PE, Tse, E, Au-Yeung, RKH, Kwong, Y-L, Srivastava, G, Iqbal, J, Yu, J, Naresh, K, Villa, D, Gascoyne, RD, Said, J, Czader, MB, Chadburn, A, Richards, KL, Rajagopalan, D, Davis, NS, Smith, EC, Palus, BC, Tzeng, TJ, Healy, JA, Lugar, PL, Datta, J, Love, C, Levy, S, Dunson, DB, Zhuang, Y, Hsi, ED, and Dave, SS. "Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2." The Journal of experimental medicine 214, no. 5 (May 2017): 1371-1386.
McKinney, M, Moffitt, AB, Gaulard, P, Travert, M, De Leval, L, Nicolae, A, Raffeld, M, Jaffe, ES, Pittaluga, S, Xi, L, Heavican, T, Iqbal, J, Belhadj, K, Delfau-Larue, MH, Fataccioli, V, Czader, MB, Lossos, IS, Chapman-Fredricks, JR, Richards, KL, Fedoriw, Y, Ondrejka, SL, Hsi, ED, Low, L, Weisenburger, D, Chan, WC, Mehta-Shah, N, Horwitz, S, Bernal-Mizrachi, L, Flowers, CR, Beaven, AW, Parihar, M, Baseggio, L, Parrens, M, Moreau, A, Sujobert, P, Pilichowska, M, Evens, AM, and Chadburn, A et al. "The Genetic Basis of Hepatosplenic T-cell Lymphoma." Cancer discovery 7, no. 4 (April 2017): 369-379.
Healy, JA, Nugent, A, Rempel, RE, Moffitt, AB, Davis, NS, Jiang, X, Shingleton, JR, Zhang, J, Love, C, Datta, J, McKinney, ME, Tzeng, TJ, Wettschureck, N, Offermanns, S, Walzer, KA, Chi, J-T, Rasheed, SAK, Casey, PJ, Lossos, IS, and Dave, SS. "GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo." Blood 127, no. 22 (June 2016): 2723-2731.
Papalas, JA, McKinney, MS, Kulbacki, E, Dave, SS, and Wang, E. "Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma." The American Journal of dermatopathology 36, no. 2 (February 2014): 148-152.
Walsh, K, McKinney, MS, Love, C, Liu, Q, Fan, A, Patel, A, Smith, J, Beaven, A, Jima, DD, and Dave, SS. "PAK1 mediates resistance to PI3K inhibition in lymphomas." Clinical cancer research : an official journal of the American Association for Cancer Research 19, no. 5 (March 2013): 1106-1115.
Love, C, Sun, Z, Jima, D, Li, G, Zhang, J, Miles, R, Richards, KL, Dunphy, CH, Choi, WWL, Srivastava, G, Lugar, PL, Rizzieri, DA, Lagoo, AS, Bernal-Mizrachi, L, Mann, KP, Flowers, CR, Naresh, KN, Evens, AM, Chadburn, A, Gordon, LI, Czader, MB, Gill, JI, Hsi, ED, Greenough, A, Moffitt, AB, McKinney, M, Banerjee, A, Grubor, V, Levy, S, Dunson, DB, and Dave, SS. "The genetic landscape of mutations in Burkitt lymphoma." Nature genetics 44, no. 12 (December 2012): 1321-1325.
Morse, MA, Hobeika, A, Serra, D, Aird, K, McKinney, M, Aldrich, A, Clay, T, Mourich, D, Lyerly, HK, Iversen, PL, and Devi, GR. "Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function." Cancer Gene Ther 19, no. 1 (January 2012): 30-37.
McKinney, M, and Arcasoy, MO. "Erythropoietin for oncology supportive care." Exp Cell Res 317, no. 9 (May 15, 2011): 1246-1254. (Review)
McKinney, MS, and Crawford, J. "Erythropoiesis-stimulating agents in older adults with cancer." In Practical Geriatric Oncology, 338-350. January 1, 2010.
Osada, T, Woo, CY, McKinney, M, Yang, XY, Lei, G, Labreche, HG, Hartman, ZC, Niedzwiecki, D, Chao, N, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine." Clin Cancer Res 15, no. 8 (April 15, 2009): 2789-2796.